Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Advancement in transporter-oriented nanoplatforms for cancer therapy70
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances56
Post-transcriptional knockdown of BRCC3 via siRNA-loaded niosomes modulates autophagy and endoplasmic reticulum stress in rotenone-induced Parkinson’s Disease model47
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis44
Polymyxin B delivery systems: smart solutions for improved antibacterial activity and reduced toxicity36
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma35
Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment34
Development, characterisation and preclinical evaluation of curcumin-loaded solid lipid nanoparticles for enhanced antiviral delivery against Zika virus infection33
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches33
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma31
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells30
Beyond drug delivery: nanoparticles as active modulators of immunometabolism for treating inflammatory diseases29
Improved antidiabetic potential of quercetin-loaded chitosan–lecithin nanoparticles for effective glycaemic control28
Correction27
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes26
Application of small interfering RNAs and drug combination for pancreatic cancer therapy26
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases25
Emerging role of ferroptosis in diabetic retinopathy: a review24
Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets24
Chitosan–β-glycerophosphate thermogelling microneedles for transdermal contraceptive delivery of levonorgestrel24
Ferroptosis-targeting drugs in breast cancer24
Pravastatin-Loaded nanostructured lipid carriers: formulation optimization and in-vivo assessment for antihyperlipidaemic effect in rats23
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice23
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review23
Correction23
0.13738083839417